Domestic Launch of SI-6603 and Resubmission of Its US Approval Application
A regulatory and commercialization theme for SI-6603, an individual drug for which the company is seeking domestic approval and launch and has proceeded to resubmit its US approval application after addressing FDA comments.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.